-
1.
公开(公告)号:US20190000902A1
公开(公告)日:2019-01-03
申请号:US16064312
申请日:2016-12-21
IPC分类号: A61K36/185 , A61K8/9789 , A61K8/49 , A61K8/368 , A61Q19/08 , A61Q17/04 , A61P17/16 , A61P29/00 , A61K31/353 , A61K31/192
摘要: The invention relates to a polyphenolic extract of passion flower seeds, in particular Passiflora incarnata or Passiflora edulis seeds, comprising at least 30 percent by weight polyphenols, expressed as gallic acid equivalent, relative to the weight of the dry extract. The invention also relates to a method for preparing an extract of said type, a composition containing same, and the cosmetic, dermatological or therapeutic use thereof.
-
公开(公告)号:US20170157019A1
公开(公告)日:2017-06-08
申请号:US15323347
申请日:2015-07-03
CPC分类号: A61K8/645 , A61K8/97 , A61K2800/74 , A61Q19/06 , A61Q19/08
摘要: The present invention relates to the use of a lupin peptide extract to prevent loss of skin firmness or to increase the firmness of skin. Advantageously, the lupin peptide extract can prevent the appearance of cellulite and/or reduce skin cellulite.
-
公开(公告)号:US20210236574A1
公开(公告)日:2021-08-05
申请号:US17239042
申请日:2021-04-23
IPC分类号: A61K36/185 , A61K8/49 , A61Q17/04 , A61Q19/08 , A61Q19/06 , A61Q17/00 , A61Q19/00 , A61K8/9789 , A61P17/16 , A61P29/00 , A61K8/368 , A61K31/192 , A61K31/353
摘要: The invention relates to a polyphenolic extract of passion flower seeds, in particular Passiflora incarnata or Passiflora edulis seeds, comprising at least 30 percent by weight polyphenols, expressed as gallic acid equivalent, relative to the weight of the dry extract. The invention also relates to a method for preparing an extract of said type, a composition containing same, and the cosmetic, dermatological or therapeutic use thereof.
-
4.
公开(公告)号:US20170326061A1
公开(公告)日:2017-11-16
申请号:US15529694
申请日:2015-11-26
CPC分类号: A61K8/97 , A61K8/9783 , A61K36/00 , A61K36/79 , A61K2800/72 , A61K2800/78 , A61Q7/00 , A61Q17/04 , A61Q19/00 , A61Q19/005 , A61Q19/08
摘要: The present invention relates to the use of a peptide and glycoside extract of Schizandra fruit as a cutaneous neurosensory agent, for improving the response of the cutaneous neurosensory system, in particular for: —improving cutaneous innervation in the basal state, —combatting age-related loss of cutaneous innervation in the basal state, advantageously for preventing loss of the cutaneous sensitivity and/or combatting thinning of the epidermis, and/or—improving cutaneous perception of the environment, more particularly for combatting burns, extreme cold and/or pain.
-
-
-